Amin Khan - May 10, 2022 Form 4 Insider Report for GreenLight Biosciences Holdings, PBC (GRNA)

Role
Chief Scientific Officer
Signature
/s/ David Kennedy, Attorney-in-fact
Stock symbol
GRNA
Transactions as of
May 10, 2022
Transactions value $
$0
Form type
4
Date filed
8/8/2022, 10:15 AM
Previous filing
Feb 4, 2022
Next filing
Jun 14, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRNA Stock Option (Right to Buy) Award $0 +319K $0.00 319K May 10, 2022 Common Stock 319K $7.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option shall vest on the first anniversary of the grant date and the remainder of the shares shall vest in 36 equal monthly installments thereafter.